[1]江丹,刘新泉,张殷建,等.自体血清治疗单纯疱疹病毒性角膜炎恢复期干眼的疗效[J].眼科新进展,2018,38(8):746-750.[doi:10.13389/j.cnki.rao.2018.0175]
　JIANG Dan,LIU Xin-Quan,ZHANG Yin-Jian,et al.Treatment effects of autologous serum on the dry eyes of convalescent herpes simplex keratitis[J].Recent Advances in Ophthalmology,2018,38(8):746-750.[doi:10.13389/j.cnki.rao.2018.0175]
点击复制

自体血清治疗单纯疱疹病毒性角膜炎恢复期干眼的疗效/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年8期
页码:
746-750
栏目:
应用研究
出版日期:
2018-08-05

文章信息/Info

Title:
Treatment effects of autologous serum on the dry eyes of convalescent herpes simplex keratitis
作者:
江丹; 刘新泉; 张殷建; 阮雯洁
200032　上海市，上海中医药大学附属龙华医院眼科
Author(s):
JIANG Dan; LIU Xin-Quan; ZHANG Yin-Jian; RUAN Wen-Jie
Department of Ophthalmology，Longhua Hosptial，Shanghai University of Traditional Chinese Medicine，Shanghai 200032，China
关键词:
自体血清; 单纯疱疹病毒性角膜炎; 干眼
Keywords:
autologous serum; herpes simplex keratitis; dry eyes
分类号:
R772
DOI:
10.13389/j.cnki.rao.2018.0175
文献标志码:
A
摘要:
目的　评价不同体积分数自体血清局部应用治疗单纯疱疹病毒性角膜炎（herpes simplex keratitis，HSK）恢复期干眼的疗效。方法　纳入2015年7月至2017年6月就诊的HSK进入恢复期合并干眼的患者69例69眼，随机分为3组：低浓度治疗组给予体积分数20%自体血清，高浓度治疗组给予体积分数50%自体血清，对照组给予重组人表皮生长因子眼液滴眼，均为每天4次。观察治疗前及治疗后7 d、14 d、28 d的眼表疾病指数（ocular surface disease index，OSDI）评分、泪液分泌试验（Schirmer’s I test，SIT）、泪膜破裂时间（break-up time，BUT）、角膜荧光素（fluorescence，FL）染色评分、角膜知觉、中央角膜厚度和角膜混浊度。结果　两治疗组治疗后OSDI评分降低，患眼SIT值增加、BUT延长、FL染色评分降低（均为P<0.05），对照组患眼仅BUT延长（P<0.05），但程度明显低于两治疗组。两治疗组治疗后患眼角膜知觉逐渐恢复，至28 d时分别为治疗前的1.21倍和1.23倍，对照组为治疗前的1.08倍。两治疗组患眼角膜水肿减退、中央角膜厚度降低并在14~28 d恢复至正常值范围；对照组患眼中央角膜厚度也较治疗前降低（P<0.05），但降低程度明显低于两治疗组；两治疗组患眼角膜混浊度减轻（均为P<0.05），而对照组则无明显变化（P>0.05）；两治疗组间各项指标差异均无统计学意义（均为P>0.05）。各组患者在治疗前健眼SIT、BUT、FL染色评分、角膜知觉、中央角膜厚度差异均无统计学意义（均为P>0.05），且均无角膜混浊，治疗后仅观察到两治疗组健眼SIT值增加、BUT延长（均为P<0.05），其余指标均无显著改变（均为P>0.05）。结论　局部应用体积分数20%和体积分数50%自体血清均能有效缓解HSK恢复期干眼症状且疗效无明显差异。
Abstract:
Objective　To evaluate the effect of different volume fractions of autologous serum (AS) on the dry eyes of convalescent herpes simplex keratitis (HSK).Methods　Totally 69 patients (69 dry eyes) of convalescent HSK in our hospital from July 2015 to June 2017 were enrolled and randomly divided into three groups.Patients were treated with 20% AS in low concentration therapy group，50% AS in high concentration therapy group，recombinant human epidermal growth factor eyedrops in control group and different eyedrops were administrated four times per day，respectively.Ocular surface disease index (OSDI)，Schirmer’s I test (SIT) value，tear break-up time(BUT)，fluorescence(FL) score，cornea perception，central cornea thickness (CCT)，degree of cornea opacity were observed before and 7 d，14 d，28 d after therapy.Results　OSDI decreased in the two therapy groups.In the HSK eyes，SIT values were increased，BUT were prolonged，FL scores were decreased in two therapy groups (all P<0.05)，while only BUT improvement was observed in control group(P<0.05) and the range of improvement was lower.Cornea perception was recovered gradually after therapy and the values were 1.21-folds and 1.23-folds in therapy groups compared with the beginning of the study，however，the value was only 1.08-folds in control group.Corneal edema was relieved and CCT was reduced to normal range during 14 d to 28 d in therapy groups，the similar alternations were observed in control group(P<0.05) and the extent was much lower.Cornea opacities were obviously improved in therapy groups (all P<0.05) while there was little alternation in control group(P>0.05).All the indexes in HSK eyes indicated no significant difference between the two therapy groups (all P>0.05).Meanwhile，there were no difference of SIT values，BUT，FL scores，cornea perception，CCT in unaffected eyes in each group(all P>0.05).There’s no obvious cornea opacity in all unaffected eyes and only increasing SIT values and prolonging BUT were observed after therapy (all P<0.05) and no significant alternations in other indexes(all P>0.05).Conclusion　Both 20% AS and 50% AS can relieve the dry eyes of convalescent HSK with equivalent therapeutic effects.

参考文献/References:

［1］　ROWE A M，LEGER A J S，JEON S，DHALIWAL D K，KNICKELBEIN J E，HENDRICKS R L.Herpes keratitis［J］.Rrog Retin Eye Res，2013，32(1)：88-101.
［2］　LIU S Y，LI Z Q，CHEN L X，ZHAO S Z.Use of corticosteroid eyedrops combined with artificial tears of dry eyes in the convalescent phase of herpes simplex keratitis［J］.Ophthalmol CHN，2013，22(2)：101-104.
刘淑英，李志清，陈露霞，赵少贞.糖皮质激素联合人工泪液治疗单纯疱疹病毒性角膜炎恢复期干眼症的效果［J］.眼科，2013，22(2)：101-104.
［3］　LIU Z G，PENG J.Diagnosis and treatment of dry eye［J］.Chin Ophthalmol Res，2008，26(3)：161-164.
刘祖国，彭娟.干眼的诊断与治疗规范［J］.眼科研究，2008，26(3)：161-164.
［4］　HONDUR A M，AKCAM H T，KARACA E E，YAZICI E H，AYDIN B.Autologous serum eye drops accelerate epithelial healing after LASEK［J］.Curr Eye Res，2016，41(1)：15-19.
［5］　ZIAKAS N G，BOBORIDIS K G，TERZIDOU C，NAOUMIDI T L，MIKROPOULOS D，GEORGIADOU E N，et al.Long-term follow up of autologous serum treatment for recurrent corneal erosions［J］.Clin Exp Ophthalmol，2010，38(7)：683-687.
［6］　SAGARA H，LIDA T，SAITO K，NOJI H，OGASAWARA M，OYAMADA H.Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease［J］.Clin Exp Ophthalmol，2012，6：1273-1279.
［7］　LEKHANONT K，JONGKHAJORNPONG P，CHOUBTUM L，CHUCKPAI-WONG V.Topical 100%serum eye drops for treating corneal epithelial defect after ocular surgery［J］.Biomed Res Int，2013，2013(3)：521315.
［8］　PAN Q，ANGELINA A，ZAMBRANO A，MARRONE M，STARK W J，HEFLIN T，et al.Autologous serum eye drops for dry eye［J］.Cochrane Database Syst Rev，2013，8(8)：CD009327.
［9］　SEMERARO F，FORBICE E，BRAGA O，BOVA A，DI S A，AZZOLINI C.Evaluation of the efficacy of 50%autologous serum eye drops in different ocular surface pathologies［J］.Bio Res Int，2014，2014(7)：826970.
［10］　LIN C，YANG M M，ZHENG Q.Development and evaluation of Chinese version questionaires of ocular surface disease index［J］.Rec Adv Ophthalmol，2013，33(1)：38-40.
林晨，杨敏敏，郑虔.眼表疾病指数量表中文版的研制和性能评价［J］.眼科新进展，2013，33(1)：38-40.
［11］　ANDO H，IDO T，KAWAI Y，YAMAMOTO T，KITAZAWA Y.Inhibition of corneal epithelial woun healing：A comparative study of mitomycin C and 5-fluorouracil［J］.Ophthalmology，1992，99(12)：1809-1814.
［12］　ZENG Q Y，JIANG H，NIU X G，WU S C，YU C T.Binocular tear film function changes in herpes simplex keratitis［J］.Rec Adv Ophthalmol，2012，32(5)：467-469.
曾庆延，蒋华，牛晓光，吴尚操，喻长泰.单纯疱疹病毒性角膜炎患者双眼泪液功能改变［J］.眼科新进展，2012，32(5)：467-469.
［13］　MA X，LU Y.Bilateral tear film alternations in patients with unilateral quiescent herpes simplex keratitis［J］.Acta Ophthalmol，2017，95(6)：629-633.
［14］　SIMARD-LEBRUN A，BOISJOLY H，AL-SAADI A，CHOREMIS J，MABON M，CHAGNON M.Association between unilateral quiscent stromal herpetic keratitis and bilateral dry eye［J］.Cornea，2010，29(11)：1291-1295.
［15］　LIU Z G.Diagnosis of dry eye［J］.Chin J Ophthalmol，2002，38(5)：318-320.
刘祖国.干眼的诊断［J］.中华眼科杂志，2002，38(5)：318-320.
［16］　HWANG J，CHUNG S H，JEON S，KWOK S K，PARK S H，KIM M S.Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjgren syndrome［J］.Cornea，2014，33(7)：663-667.
［17］　TSUBOTA K，GOTO E，FUJITA H，ONO M，INOUE H，SAITO I，et al.Treatment of dry eye by autologous serum application in Sjgren’s syndrome［J］.Br J Ophthalmol，1999，83(4)：390-395.
［18］　JONES L，DOWNIE L E，KORB D，BENITEZ-DEL-CASTILLO J M，DANA R，DENG S X，et al.TFOS DEWS II management and therapy report［J］.Ocul Surf，2017，15(3)：575-628.
［19］　MLLER R T，POURMIRZAIE R，PAVAN-LANGSTON D，CAVALCANTI B M，AGGARWAL S，COLON C，et al.In vivo confocal microscopy demonstrates bilateral loss of endothelial cells in unilateral herpes simplex keratitis［J］.IOVS，2015，56(8)：4899-4906.
［20］　CRUZAT A，QAZI Y，HAMRAH P.In vivo confocal microscopy of corneal nerves in health and disease［J］.Ocul Surf，2017，15(1)：15-47.
［21］　JOVER B A，MARQUEZ PEIRO J F，MARQUES K，MONTS C N，SELVA O J.Effectiveness of 100%autologous serum drops in ocular surface disorders［J］.Farm Hosp，2011，35(1)：8-13.
［22］　ESQUENAZI S，HE J，BAZAN H E，BAZAN N G.Use of autologous serum in corneal epithelial defects post-lamellar surgery［J］.Cornea，2005，24(8)：992-997.

相似文献/References:

[1]任予斌 谷川莎.角膜板层刀制瓣联合自体血清角膜基质层间注射治疗大泡性角膜病变[J].眼科新进展,2013,33(6):000.
[2]聂爱芹 席兴华 程芳 雷璐贇 王虹.玉屏风散对单纯疱疹病毒性角膜炎模型小鼠细胞免疫功能的影响[J].眼科新进展,2013,33(4):000.
[3]陈鹤,陆晓和.不同临床背景下角膜新生血管发生机制的研究进展[J].眼科新进展,2019,39(4):394.[doi:10.13389/j.cnki.rao.2019.0090]
　CHEN He,LU Xiao-He.Progress on the mechanisms of corneal neovascularization in different clinical backgrounds[J].Recent Advances in Ophthalmology,2019,39(8):394.[doi:10.13389/j.cnki.rao.2019.0090]

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81574028）；龙医学者项目（编号：LYTD-50）
更新日期/Last Update: 2018-08-09